Celgene Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

Celgene Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


November 29, 2012
32 Pages - SKU: ICDR4922235
License type:
Online Download      US $125.00
Site License      US $250.00
Global Site License      US $375.00
Synopsis

ICD Research's Celgene Corporation: Pharmaceuticals and Healthcare - Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history.

Summary

This report is a crucial resource for industry executives and anyone looking to access key information about Celgene Corporation

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
  • Examines and identifies key information and issues about Celgene Corporation for business intelligence requirements.
  • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
  • Provides data on company financial performance and competitive benchmarking.
  • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries.
Reasons To Buy
  • Quickly enhance your understanding of Celgene Corporation
  • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
  • Increase business/sales activities by understanding your competitors’ businesses better.
  • Recognize potential partnerships and suppliers.
Key Highlights

Celgene Corporation (Celgene) is an integrated biopharmaceutical company. It primarily focuses on the research, development, manufacture, and marketing of therapies for the treatment of cancer and immune-inflammatory-related diseases. The company has three marketed products, REVLIMID, THALOMID and VIDAZA, ABRAXANE, and ISTODAX. The company's operations are spread across more than 65 countries and regions, including Europe, Latin America, Middle East, Asia-Pacific and Canada. It operates outside the US, through its subsidiaries and distributors. Celgene is headquartered in Summit (New Jersey), the US.



More Pharmaceuticals Company reports by iCD Research

Shire Plc : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report by iCD Research
Shire Plc : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial ReportSynopsisICD Research's Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & ...
Johnson and Johnson : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report by iCD Research
Johnson and Johnson : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial ReportSynopsisICD Research's Johnson & Johnson : Pharmaceuticals & Healthcare - Company Profile, ...
Valeant Pharmaceuticals International : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report by iCD Research
Valeant Pharmaceuticals International : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial ReportSynopsisICD Research's Valeant Pharmaceuticals International : Pharmaceuticals and Healthcare - Company Profile, ...
Par Pharmaceutical Companies, Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report by iCD Research
Par Pharmaceutical Companies, Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT ReportSynopsisICD Research's Par Pharmaceutical Companies, Inc.: Pharmaceuticals and Healthcare - Company Profile & ...
See all reports like this >>